<?xml version="1.0" encoding="UTF-8"?><gbm:tcga_bcr xmlns:gbm="http://tcga.nci/bcr/xml/clinical/gbm/2.6" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.6" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/gbm/followup/2.6/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.6" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.6" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.6" xmlns:shared="http://tcga.nci/bcr/xml/clinical/shared/2.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" schemaVersion="2.6" xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/gbm/2.6 http://tcga-data.nci.nih.gov/docs/xsd/BCR/tcga.nci/bcr/xml/clinical/gbm/2.6/TCGA_BCR.GBM_Clinical.xsd">
    <admin:admin>
        <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
        <admin:batch_number xsd_ver="1.17">8.52.0</admin:batch_number>
        <admin:disease_code xsd_ver="2.6">GBM</admin:disease_code>
        <admin:day_of_dcc_upload xsd_ver="1.17">2</admin:day_of_dcc_upload>
        <admin:month_of_dcc_upload xsd_ver="1.17">1</admin:month_of_dcc_upload>
        <admin:year_of_dcc_upload xsd_ver="1.17">2014</admin:year_of_dcc_upload>
        <admin:patient_withdrawal>
            <admin:withdrawn>false</admin:withdrawn>
        </admin:patient_withdrawal>
    </admin:admin>
    <gbm:patient>
        <shared:tumor_tissue_site cde="3427536" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" source_system_identifier="1624360" tier="2" xsd_ver="2.6">Brain</shared:tumor_tissue_site>
        <shared:histological_type cde="3081934" display_order="8" owner="TSS" preferred_name="histologic_diagnosis" procurement_status="Completed" restricted="false" source_system_identifier="1624369" tier="2" xsd_ver="2.5">Untreated primary (de novo) GBM</shared:histological_type>
        <gbm:prior_glioma cde="2786111" display_order="6" owner="TSS" preferred_name="history_lgg_dx_of_brain_tissue" procurement_status="Completed" restricted="false" source_system_identifier="1624352" tier="1" xsd_ver="1.9">NO</gbm:prior_glioma>
        <shared:gender cde="2200604" display_order="9" owner="TSS" preferred_name="gender" procurement_status="Completed" restricted="false" source_system_identifier="1624355" tier="1" xsd_ver="1.8">FEMALE</shared:gender>
        <shared:vital_status cde="5" display_order="23" owner="TSS" preferred_name="vital_status" procurement_status="Completed" restricted="false" source_system_identifier="1624354" tier="2" xsd_ver="2.6">Dead</shared:vital_status>
        <shared:days_to_birth cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">-27519</shared:days_to_birth>
        <shared:days_to_death cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">111</shared:days_to_death>
        <shared:days_to_last_followup cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">80</shared:days_to_last_followup>
        <shared:race cde="2192199" display_order="14" owner="TSS" preferred_name="race" procurement_status="Completed" restricted="false" source_system_identifier="1624343" tier="2" xsd_ver="1.8">WHITE</shared:race>
        <shared:bcr_patient_barcode cde="2673794" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" xsd_ver="1.8">TCGA-12-0692</shared:bcr_patient_barcode>
        <shared:tissue_source_site cde="" owner="TSS" procurement_status="Completed" restricted="false" xsd_ver="2.4">12</shared:tissue_source_site>
        <shared:patient_id cde="" owner="TSS" procurement_status="Completed" restricted="false" xsd_ver="2.4">0692</shared:patient_id>
        <shared:bcr_patient_uuid cde="" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" xsd_ver="2.3">24164e89-16ae-48c1-a464-9be94141deef</shared:bcr_patient_uuid>
        <shared:informed_consent_verified cde="2714689" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" tier="2" xsd_ver="2.4">YES</shared:informed_consent_verified>
        <shared:icd_o_3_site cde="3226281" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" tier="2" xsd_ver="2.4">C71.9</shared:icd_o_3_site>
        <shared:icd_o_3_histology cde="3226275" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" tier="2" xsd_ver="2.4">9440/3</shared:icd_o_3_histology>
        <shared:icd_10 cde="3226287" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" tier="2" xsd_ver="2.4">C71.9</shared:icd_10>
        <shared:days_to_initial_pathologic_diagnosis cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">0</shared:days_to_initial_pathologic_diagnosis>
        <shared:age_at_initial_pathologic_diagnosis cde="" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.16">75</shared:age_at_initial_pathologic_diagnosis>
        <shared:year_of_initial_pathologic_diagnosis cde="2896960" display_order="20" owner="TSS" preferred_name="initial_pathologic_dx_year" procurement_status="Completed" restricted="true" source_system_identifier="1624358" tier="1" xsd_ver="1.12">2000</shared:year_of_initial_pathologic_diagnosis>
        <shared:person_neoplasm_cancer_status cde="2759550" display_order="32" owner="TSS" preferred_name="tumor_status" procurement_status="Completed" restricted="false" source_system_identifier="1624367" tier="2" xsd_ver="1.9">WITH TUMOR</shared:person_neoplasm_cancer_status>
        <shared:day_of_form_completion cde="2975716" display_order="999" owner="TSS" preferred_name="form_completion_day" procurement_status="Completed" restricted="true" source_system_identifier="1624370" tier="2" xsd_ver="2.2">11</shared:day_of_form_completion>
        <shared:month_of_form_completion cde="2975718" display_order="999" owner="TSS" preferred_name="form_completion_month" procurement_status="Completed" restricted="true" source_system_identifier="1624359" tier="2" xsd_ver="2.2">12</shared:month_of_form_completion>
        <shared:year_of_form_completion cde="2975720" display_order="999" owner="TSS" preferred_name="form_completion_year" procurement_status="Completed" restricted="true" source_system_identifier="1624350" tier="2" xsd_ver="2.2">2008</shared:year_of_form_completion>
        <shared:ethnicity cde="2192217" display_order="15" owner="TSS" preferred_name="ethnicity" procurement_status="Completed" restricted="false" source_system_identifier="1624344" tier="2" xsd_ver="1.9">NOT HISPANIC OR LATINO</shared:ethnicity>
        <shared:history_of_neoadjuvant_treatment cde="3382737" display_order="17" owner="TSS" preferred_name="history_neoadjuvant_treatment" procurement_status="Completed" restricted="false" source_system_identifier="1624366" tier="1" xsd_ver="2.4">No</shared:history_of_neoadjuvant_treatment>
        <shared:initial_pathologic_diagnosis_method cde="2757941" display_order="21" owner="TSS" preferred_name="method_initial_path_dx" procurement_status="Completed" restricted="false" source_system_identifier="1624341" tier="2" xsd_ver="2.5">Excisional Biopsy</shared:initial_pathologic_diagnosis_method>
        <shared:anatomic_neoplasm_subdivision cde="3108203" display_order="9999" owner="TSS" preferred_name="" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.6"/>
        <shared:karnofsky_performance_score cde="2003853" display_order="33" owner="TSS" preferred_name="karnofsky_score" procurement_status="Completed" restricted="false" source_system_identifier="1624353" tier="2" xsd_ver="1.8">60</shared:karnofsky_performance_score>
        <shared:eastern_cancer_oncology_group cde="88" display_order="34" owner="TSS" preferred_name="ecog_score" procurement_status="Not Available" restricted="false" source_system_identifier="1624347" tier="2" xsd_ver="1.9"/>
        <shared:performance_status_scale_timing cde="2792763" display_order="35" owner="TSS" preferred_name="performance_status_timing" procurement_status="Completed" restricted="false" source_system_identifier="1624351" tier="2" xsd_ver="1.9">Pre-Adjuvant Therapy</shared:performance_status_scale_timing>
        <rx:drugs>
            <rx:drug>
                <rx:tx_on_clinical_trial cde="2503808" display_order="4" owner="TSS" preferred_name="clinical_trial_indicator" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.5"/>
                <rx:regimen_number cde="2673845" display_order="999" owner="TSS" preferred_name="regimen_number" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.1"/>
                <rx:bcr_drug_barcode owner="TSS" procurement_status="Completed" restricted="false" xsd_ver="1.15">TCGA-12-0692-D23571</rx:bcr_drug_barcode>
                <rx:bcr_drug_uuid cde="" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" xsd_ver="2.3">4d98309a-23d9-4329-8cce-8413e6bf2891</rx:bcr_drug_uuid>
                <rx:total_dose cde="1515" display_order="999" owner="TSS" preferred_name="total_dose" procurement_status="Completed" restricted="false" source_system_identifier="1624424" tier="2" xsd_ver="2.1">200</rx:total_dose>
                <rx:total_dose_units cde="3088785" display_order="999" owner="TSS" preferred_name="pharmaceutical_tx_total_dose_units" procurement_status="Completed" restricted="false" source_system_identifier="1624420" tier="2" xsd_ver="2.1">mg/m2</rx:total_dose_units>
                <rx:prescribed_dose cde="2184728" display_order="999" owner="TSS" preferred_name="prescribed_dose" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.1"/>
                <rx:prescribed_dose_units cde="3065815" display_order="999" owner="TSS" preferred_name="pharmaceutical_tx_dose_units" procurement_status="Completed" restricted="false" source_system_identifier="1624429" tier="2" xsd_ver="2.1">mg/m2</rx:prescribed_dose_units>
                <rx:number_cycles cde="62590" display_order="999" owner="TSS" preferred_name="pharma_adjuvant_cycles_count" procurement_status="Completed" restricted="false" source_system_identifier="1624421" tier="2" xsd_ver="1.8">1</rx:number_cycles>
                <rx:days_to_drug_therapy_start cde="" owner="TSS" precision="day" procurement_status="Completed" tier="2" xsd_ver="1.16">14</rx:days_to_drug_therapy_start>
                <rx:days_to_drug_therapy_end cde="" owner="TSS" precision="day" procurement_status="Completed" tier="2" xsd_ver="1.16">45</rx:days_to_drug_therapy_end>
                <rx:therapy_types>
                    <rx:therapy_type cde="2793530" display_order="7" owner="TSS" preferred_name="pharmaceutical_therapy_type" procurement_status="Completed" restricted="false" source_system_identifier="1624425" tier="2" xsd_ver="2.1">Chemotherapy</rx:therapy_type>
                    <rx:therapy_type_notes cde="2001762" display_order="999" owner="TSS" preferred_name="pharma_type_other" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.1"/>
                </rx:therapy_types>
                <rx:drug_name cde="2975232" display_order="22" owner="TSS" preferred_name="pharmaceutical_therapy_drug_name" procurement_status="Completed" restricted="false" source_system_identifier="1624428" tier="1" xsd_ver="1.10">Temozolomide</rx:drug_name>
                <rx:clinical_trail_drug_classification cde="3378323" display_order="6" owner="TSS" preferred_name="clinical_trial_drug_classification" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.5"/>
                <shared:regimen_indication cde="2793511" display_order="999" owner="TSS" preferred_name="therapy_regimen" procurement_status="Completed" restricted="false" source_system_identifier="1624423" tier="2" xsd_ver="1.12">ADJUVANT</shared:regimen_indication>
                <shared:regimen_indication_notes cde="2793516" display_order="999" owner="TSS" preferred_name="therapy_regimen_other" procurement_status="Not Applicable" restricted="false" source_system_identifier="1624430" tier="2" xsd_ver="1.12"/>
                <rx:route_of_administrations>
                    <rx:route_of_administration cde="2003586" display_order="999" owner="TSS" preferred_name="route_of_administration" procurement_status="Completed" restricted="false" source_system_identifier="1624431" tier="2" xsd_ver="2.3">Oral</rx:route_of_administration>
                </rx:route_of_administrations>
                <rx:therapy_ongoing cde="3103479" display_order="12" owner="TSS" preferred_name="pharmaceutical_tx_ongoing_indicator" procurement_status="Completed" restricted="false" source_system_identifier="1624427" tier="2" xsd_ver="2.2">NO</rx:therapy_ongoing>
                <shared:measure_of_response cde="2857291" display_order="17" owner="TSS" preferred_name="treatment_best_response" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.5"/>
                <shared:day_of_form_completion cde="2975716" display_order="999" owner="TSS" preferred_name="form_completion_day" procurement_status="Completed" restricted="true" source_system_identifier="1624422" tier="2" xsd_ver="2.2">24</shared:day_of_form_completion>
                <shared:month_of_form_completion cde="2975718" display_order="999" owner="TSS" preferred_name="form_completion_month" procurement_status="Completed" restricted="true" source_system_identifier="1624415" tier="2" xsd_ver="2.2">4</shared:month_of_form_completion>
                <shared:year_of_form_completion cde="2975720" display_order="999" owner="TSS" preferred_name="form_completion_year" procurement_status="Completed" restricted="true" source_system_identifier="1624418" tier="2" xsd_ver="2.2">2009</shared:year_of_form_completion>
            </rx:drug>
        </rx:drugs>
        <rad:radiations/>
        <gbm:follow_ups>
            <follow_up_v1.0:follow_up sequence="1" version="1.0">
                <shared:bcr_followup_barcode cde="" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" xsd_ver="2.5">TCGA-12-0692-F23570</shared:bcr_followup_barcode>
                <shared:bcr_followup_uuid cde="" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" xsd_ver="2.5">a0ef671a-89da-4f7f-9bf0-b6dd423eabd0</shared:bcr_followup_uuid>
                <shared:vital_status cde="5" display_order="23" owner="TSS" preferred_name="vital_status" procurement_status="Completed" restricted="false" source_system_identifier="1624407" tier="2" xsd_ver="2.6">Dead</shared:vital_status>
                <shared:days_to_last_followup cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">80</shared:days_to_last_followup>
                <shared:days_to_death cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">111</shared:days_to_death>
                <nte:days_to_new_tumor_event_after_initial_treatment cde="" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
                <nte:additional_surgery_locoregional_procedure cde="3008755" display_order="57" owner="TSS" preferred_name="new_tumor_event_surgery" procurement_status="Completed" restricted="false" source_system_identifier="1624403" tier="2" xsd_ver="2.2">NO</nte:additional_surgery_locoregional_procedure>
                <nte:days_to_additional_surgery_locoregional_procedure cde="" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="2.2"/>
                <shared:days_to_tumor_progression cde="" owner="TSS" precision="day" procurement_status="Completed" tier="2" xsd_ver="1.16">35</shared:days_to_tumor_progression>
                <shared:days_to_tumor_recurrence cde="" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="1.16"/>
                <shared:chemo_therapy cde="2756823" display_order="37" owner="TSS" preferred_name="adjuvant_pharmaceutical_treatment" procurement_status="Completed" restricted="false" source_system_identifier="1624381" tier="1" xsd_ver="1.9">YES</shared:chemo_therapy>
                <shared:immuno_therapy cde="2756814" display_order="38" owner="TSS" preferred_name="immunotherapy_adjuvant" procurement_status="Completed" restricted="false" source_system_identifier="1624380" tier="1" xsd_ver="1.9">NO</shared:immuno_therapy>
                <shared:hormonal_therapy cde="2199669" display_order="39" owner="TSS" preferred_name="hormone_tx_adjuvant" procurement_status="Completed" restricted="false" source_system_identifier="1624378" tier="1" xsd_ver="1.9">NO</shared:hormonal_therapy>
                <shared:targeted_molecular_therapy cde="2785850" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" source_system_identifier="1624372" tier="2" xsd_ver="1.9">NO</shared:targeted_molecular_therapy>
                <shared:radiation_therapy cde="2005312" display_order="36" owner="TSS" preferred_name="radiation_treatment_adjuvant" procurement_status="Completed" restricted="false" source_system_identifier="1624376" tier="1" xsd_ver="1.9">NO</shared:radiation_therapy>
                <shared:person_neoplasm_cancer_status cde="2759550" display_order="32" owner="TSS" preferred_name="tumor_status" procurement_status="Completed" restricted="false" source_system_identifier="1624400" tier="2" xsd_ver="1.9">WITH TUMOR</shared:person_neoplasm_cancer_status>
                <shared:additional_radiation_therapy cde="3008761" display_order="9999" owner="TSS" preferred_name="" procurement_status="Completed" restricted="false" source_system_identifier="1624409" tier="2" xsd_ver="2.2">NO</shared:additional_radiation_therapy>
                <follow_up_v1.0:additional_chemo_therapy cde="2650626" display_order="68" owner="TSS" preferred_name="new_tumor_event_chemo_tx" procurement_status="Completed" restricted="false" source_system_identifier="1624384" tier="2" xsd_ver="1.9">NO</follow_up_v1.0:additional_chemo_therapy>
                <follow_up_v1.0:additional_immuno_therapy cde="2759828" display_order="69" owner="TSS" preferred_name="new_tumor_event_immunotherapy" procurement_status="Completed" restricted="false" source_system_identifier="1624393" tier="2" xsd_ver="1.9">NO</follow_up_v1.0:additional_immuno_therapy>
                <shared:additional_pharmaceutical_therapy cde="3427616" display_order="999" owner="TSS" preferred_name="new_tumor_event_pharmaceutical_tx" procurement_status="Completed" restricted="false" source_system_identifier="1624402" tier="2" xsd_ver="2.2">NO</shared:additional_pharmaceutical_therapy>
                <follow_up_v1.0:additional_drug_therapy cde="2786150" display_order="71" owner="TSS" preferred_name="new_tumor_event_targeted_therapy" procurement_status="Completed" restricted="false" source_system_identifier="1624410" tier="2" xsd_ver="1.9">NO</follow_up_v1.0:additional_drug_therapy>
                <nte:additional_surgery_metastatic_procedure cde="3008757" display_order="62" owner="TSS" preferred_name="new_tumor_event_surgery_met" procurement_status="Completed" restricted="false" source_system_identifier="1624374" tier="2" xsd_ver="2.2">NO</nte:additional_surgery_metastatic_procedure>
                <nte:days_to_additional_surgery_metastatic_procedure cde="" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="2.2"/>
                <shared:day_of_form_completion cde="2975716" display_order="999" owner="TSS" preferred_name="form_completion_day" procurement_status="Completed" restricted="true" source_system_identifier="1624383" tier="2" xsd_ver="2.2">11</shared:day_of_form_completion>
                <shared:month_of_form_completion cde="2975718" display_order="999" owner="TSS" preferred_name="form_completion_month" procurement_status="Completed" restricted="true" source_system_identifier="1624385" tier="2" xsd_ver="2.2">12</shared:month_of_form_completion>
                <shared:year_of_form_completion cde="2975720" display_order="999" owner="TSS" preferred_name="form_completion_year" procurement_status="Completed" restricted="true" source_system_identifier="1624389" tier="2" xsd_ver="2.2">2008</shared:year_of_form_completion>
                <shared:followup_case_report_form_submission_reason cde="3233305" display_order="4" owner="TSS" preferred_name="followup_reason" procurement_status="Not Available" restricted="false" tier="2" xsd_ver="2.5"/>
                <shared:karnofsky_performance_score cde="2003853" display_order="33" owner="TSS" preferred_name="karnofsky_score" procurement_status="Completed" restricted="false" source_system_identifier="1624388" tier="2" xsd_ver="1.8">60</shared:karnofsky_performance_score>
                <shared:eastern_cancer_oncology_group cde="88" display_order="34" owner="TSS" preferred_name="ecog_score" procurement_status="Not Available" restricted="false" source_system_identifier="1624390" tier="2" xsd_ver="1.9"/>
                <shared:performance_status_scale_timing cde="2792763" display_order="35" owner="TSS" preferred_name="performance_status_timing" procurement_status="Completed" restricted="false" source_system_identifier="1624396" tier="2" xsd_ver="1.9">Pre-Adjuvant Therapy</shared:performance_status_scale_timing>
            </follow_up_v1.0:follow_up>
        </gbm:follow_ups>
    </gbm:patient>
</gbm:tcga_bcr>